# A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women

> **NCT00630539** · PHASE2 · COMPLETED · sponsor: **Shionogi** · enrollment: 126 (actual)

## Conditions studied

- Atrophy
- Vaginal Diseases

## Interventions

- **DRUG:** Placebo
- **DRUG:** Ospemifene 5 mg
- **DRUG:** Ospemifene 15 mg
- **DRUG:** Ospemifene 30 mg

## Key facts

- **NCT ID:** NCT00630539
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-01
- **Final completion:** 2008-02
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2013-06-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00630539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00630539, "A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00630539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*